Subtype
Multiple Endocrine Neoplasia Type 1
CI-CAN-00001240Explore in graph →
Non-malignant2 active trials
Loading cancer entity…
Subtype
CI-CAN-00001240Explore in graph →
Clinical trials
15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02753686 | Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy(Treat ER+ight) | completed | — | 440 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 15, 2023 | clinicaltrials |
| NCT05061784 | Routine Transcervical Thymectomy in MEN-1 Patients | completed | — | 7 | National University Health System, SingaporeOTHER |
| 1 |
| Sep 30, 2021 |
| clinicaltrials |
| NCT00454363 | Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer | completed | Phase 2 | 52 | National Cancer Institute (NCI)NIH | 1 | Apr 3, 2020 | clinicaltrials |
| NCT02101918 | Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | Mar 23, 2020 | clinicaltrials |
| NCT01794676 | Genetic Evaluation of Families With Endocrine Cancers(MEN1) | completed | — | 9 | Jersey Shore University Medical CenterOTHER | 1 | Jun 16, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Feb 15, 2023source: clinicaltrials